Ayşe Yılmaz
Gaziosmanpaşa University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Ayşe Yılmaz.
Canadian Journal of Neurological Sciences | 2008
Yuksel Kaplan; Handan Inonu; Ayşe Yılmaz; Serpil Ocal
OBJECTIVE To evaluate the prevalence of restless legs syndrome (RLS) in patients with chronic obstructive pulmonary disease (COPD) and the relationship between RLS and clinical/laboratory findings of COPD. METHODS One hundred and thirty-four COPD patients without secondary causes of RLS were included. Thirty-nine (29.1%) patients were diagnosed with RLS and classified as Group 1. The control group consisted of 65 age-matched COPD patients without RLS. Group 1 was divided into subgroups according to the Johns Hopkins Severity (JHS) scale. Patients with a score of 0, 1, or 2 were classified as JHS 0-2 and those with a score of 3 as JHS 3. Group 1 and the control group and subgroups were compared for clinical and laboratory characteristics. RESULTS We found that the duration of COPD was longer and that airway obstruction, hypercapnia, and hypoxia were more evident in patients with RLS than those without. Similar differences were also detected between JHS subgroups 3 (more severe) and 0-2. Polyneuropathy frequency was significantly higher in Group 1 compared to controls. However, Group 1 subgroups showed a similar frequency of polyneuropathy. In a multivariate analysis, hypercapnia made a significant independent contribution to both JHS 0-2 and JHS 3 patients when RLS severity was set as the dependent variable. Polyneuropathy and the duration of COPD were significant independent variables for patients in the JHS 3 subgroup. Polyneuropathy was the strongest predictor for the JHS 3 patients. CONCLUSIONS We conclude that RLS is frequent in COPD, particularly in patients with severe hypoxemia/hypercapnia and in late stages of the disease.
Clinics | 2011
Ayşe Yılmaz; Birgul Elbozan Cumurcu; Turker Tasliyurt; Abdulkadir Geylani Sahan; Yusuf Ustun; Ilker Etikan
OBJECTIVES: The goals of the study were the following: 1) to determine the frequency of psychiatric disorders and irritable bowel syndrome in patients with asthma and 2) to compare the frequency of these disorders in patients with asthma to their frequency in healthy controls. INTRODUCTION: Patients with asthma have a higher frequency of irritable bowel syndrome and psychiatric disorders. METHODS: We evaluated 101 patients with bronchial asthma and 67 healthy subjects. All subjects completed the brief version of the Bowel Symptoms Questionnaire and a structured clinical interview for DSM-IV axis disorders (SCID-I/CV). RESULTS: There were 37 cases of irritable bowel syndrome in the group of 101 stable asthma patients (36.6%) and 12 cases in the group of 67 healthy subjects (17.9%) (p = 0.009). Irritable bowel syndrome comorbidity was not related to the severity of asthma (p = 0.15). Regardless of the presence of irritable bowel syndrome, psychiatric disorders in asthma patients (52/97; 53.6%) were more common than in the control group (22/63, 34.9%) (p = 0.02). Although psychiatric disorders were more common in asthma patients with irritable bowel syndrome (21/35, 60%) than in those without irritable bowel syndrome (31/62, 50%), the difference was not significant (p = 0.34). In asthma patients with irritable bowel syndrome and psychiatric disorders, the percentage of forced expiratory volume in 1 s (FEV1) was lower than it was in those with no comorbidities (p = 0.02). CONCLUSIONS: Both irritable bowel syndrome and psychiatric disorders were more common in asthma patients than in healthy controls. Psychiatric disorders were more common in asthma patients with irritable bowel syndrome than in those without irritable bowel syndrome, although the differences failed to reach statistical significance. In asthma patients with IBS and psychiatric disorders, FEV1s were significantly lower than in other asthma patients. It is important for clinicians to accurately recognize that these comorbid conditions are associated with additive functional impairment.
Acta Radiologica | 2013
Ruken Yuksekkaya; Fatih Çelikyay; Ayşe Yılmaz; Sule Arslan; Ahmet Inanir; Handan Inonu; Çağlar Deniz
Background Pulmonary involvement in rheumatoid arthritis (RA) is common and encompasses a large spectrum of disease with different treatment options and prognoses. Therefore, assessment of these patients with multidetector computed tomography (MDCT) is vital. Purpose To evaluate the MDCT pulmonary findings of patients with RA and to compare these findings with the clinical status. Material and Methods Chest MDCT scans of 85 patients with RA between 2006–2012 were assessed. One patient with a pulmonary infection was excluded from the study. MDCT findings and distribution of the CT findings were examined, and patients were classified according to the predominant CT pattern. The pulmonary function test (PFT) results and categories, demographic characteristics, and clinical status of some of the patients for whom the results were obtained were evaluated, and the CT findings, PFT results, demographic characteristics, and clinical status were compared. Results The study group consisted of 20 men (mean age, 58.1 years ± 13.1; range, 15–77 years) and 64 women (mean age, 55.3 years ± 11.5; range, 30–84 years). The most frequent findings were nodules (78.6%) and pleural thickening (48.8%). The most common CT patterns were follicular bronchiolitis (FB) in 28 (33.3%) patients and nodular disease (ND) in 12 (14.3%) others. There was no statistically significant difference between the CT findings and PFT results, and no statistically significant difference was noted in the CT findings between symptomatic and asymptomatic patients. In addition, there were some patients who exhibited no symptoms and/or had abnormal PFT results but had abnormal CT findings. Conclusion Rheumatoid arthritis is associated with a high frequency of CT findings and CT patterns, with nodules and pleural thickening being the most common CT findings and FB and ND being the most common CT patterns. MDCT identification of patients with RA may be helpful in the evaluation of pulmonary disease, even in patients without symptoms and PFT abnormalities.
Nigerian Journal of Clinical Practice | 2014
Bs Tiryaki; Turker Tasliyurt; Berna Murat Yelken; Safak Sahin; Faruk Kutluturk; Handan Inonu Koseoglu; Banu Ozturk; Ayşe Yılmaz
BACKGROUND There have been limited numbers of studies on patients with chronic kidney disease (CKD) to determine oxidative stress in exhaled breath condensate (EBC). Those two studies have been carried out on hemodialysis patients, and hydrogen peroxide and nitric oxide have been studied in order to show oxidative stress on EBC. AIMS We investigated oxidative stress in EBC evaluating 8-isoprostane levels on different stages of CKD. MATERIALS AND METHODS A total of 81 patients with 2-4 CKD stages have been evaluated prospectively. The patients have been categorized into three groups according to their CKD stages. For biochemical analysis, blood and breathing air samples were taken. 8-isoprostane has been measured using immunoassay method as the indicator of oxidative stress in EBC. RESULTS 8-isoprostane values were 8.19 ± 4.56, 13.89 ± 8.70, and 14.20 ± 10.68 pg/min group 1, 2, and 3, respectively; and the EBC 8-isoprostane levels increased significantly as CKD stages advanced (P0 = 0.018). There was a statistically significant reverse correlation between 8-isoprostane and glomerular filtration rate (GFR; r = -0.275; P = 0.014), but not between 8-isoprostane and C-reactive protein (r = -0.183; P = 0.177). CONCLUSIONS We determined the level of 8-isoprostane in EBC of patients with different stages of CKD and showed that the level of 8-isoprostane significantly increased through the progress of CKD. We consider that our study is important because there have been limited number of studies that evaluate oxidative stress in CKD using EBC which is a noninvasive method.
JRSM Open | 2014
Recep Sade; Ruken Yuksekkaya; Fatih Çelikyay; Ayşe Yılmaz; Serhat Celikel; Mehmet Yuksekkaya
Paratracheal air cysts (PTACs) are frequently and incidentally found on computed tomography (CT) examinations of the chest, neck, and spine. Aetiology, pathophysiology, clinical and radiological relevance, and accompanying airway and parenchymal pathologies of PTACs are not known. A limited number of studies have discussed the association between PTACs and radiological or clinical abnormalities. Goo et al. and Kim et al. reported a relationship between emphysema and PTACs. However, Cheng et al., Buterbaugh et al., and Bae et al. found no association between emphysema and PTACs. Most patients are asymptomatic. The aim of this study was to investigate the prevalence of PTAC and the association between the PTACs and emphysema, bronchiectasis, pneumothorax, bullea, and sternotomies on multidetector CT (MDCT) examinations.
Türkiye Klinikleri Archives of Lung | 2016
Sibel Doruk; Handan Inönü Köseoğlu; Gülgün Yenişehirli; Ilker Etikan; Dursun Ali Sağlam; Ayşe Yılmaz; Suheyla Uzun Kaya; Özgür Günal
15 osocomial infections are related to prolonged hospitalization stays and increased mortality and morbidity.1 Among microorganisms, Acinetobacter ssp plays an important role, and in recent years its prevalence in intensive care unit (ICU) patients has risen.2,3 A. baumannii is an aerobic, Gram-negative, non-fermentative bacteria, which is the most Multidrug Resistance Among A. baumannii Isolates from Intensive Care Unit: A Four Years Retrospective Study
Iranian Journal of Allergy Asthma and Immunology | 2014
Ayşe Yılmaz; Birgul Elbozan Cumurcu; Ilker Etikan; Ekrem Hasbek; Sibel Doruk
Respiratory Case Reports | 2013
Ruken Yuksekkaya; Fatih Çelikyay; Ayşe Yılmaz; Handan Inonu; Dogan Koseoglu; Recep Sade
Turkish Thoracic Journal/Turk Toraks Dergisi | 2010
Handan Inonu; Dogan Koseoglu; Cemal Pazarli; Ayşe Yılmaz; Sibel Doruk; Gülgün Yenişehirli; Zehra Seyfikli
Diagnostic Cytopathology | 2009
Resit Dogan Koseoglu; Ayşe Yılmaz; Handan Inonu; Zehra Seyfikli; Ahmet C. Caliskan; Berat Acu; Ali Yeginsu